Neurosense Therapeutics Ltd (NRSN) — Net Asset Quality Index
Neurosense Therapeutics Ltd (NRSN) has a Net Asset Quality Index of -151.8% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.03 Million minus total liabilities of $2.59 Million yields net assets of $-1.56 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read debt load of Neurosense Therapeutics Ltd for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Neurosense Therapeutics Ltd Net Asset Quality Index Over Time (2019–2025)
This chart shows how Neurosense Therapeutics Ltd's Net Asset Quality Index has evolved across 7 annual periods from 2019 to 2025. As of December 2025, the index stands at -151.8%, representing net assets of $-1.56 Million against total assets of $1.03 Million USD. For live market cap and overall valuation, see NRSN market cap.
Annual Net Asset Quality Index for Neurosense Therapeutics Ltd (2019–2025)
The table below presents the year-by-year Net Asset Quality Index for Neurosense Therapeutics Ltd from 2019 to 2025, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check NRSN capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -151.8% | $-1.56 Million | $1.03 Million | $2.59 Million | ▼ -208.2 pp |
| 2024 | 56.5% | $2.58 Million | $4.58 Million | $1.99 Million | ▲ +111.7 pp |
| 2023 | -55.2% | $-1.76 Million | $3.19 Million | $4.94 Million | ▼ -128.1 pp |
| 2022 | 72.9% | $5.62 Million | $7.71 Million | $2.09 Million | ▼ -5.9 pp |
| 2021 | 78.8% | $9.01 Million | $11.43 Million | $2.42 Million | ▼ -5.8 pp |
| 2020 | 84.6% | $659.00K | $779.00K | $120.00K | ▼ -11.5 pp |
| 2019 | 96.1% | $918.00K | $955.00K | $37.00K | — |